Tiansheng Pharmaceutical Group Co., Ltd.
SZSE:002872.SZ
4.97 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 118.161 | 129.566 | 145.38 | 172.941 | 113.067 | 135.92 | 157.407 | 202.24 | 134.404 | 134.995 | 135.353 | 134.849 | 106.835 | 160.971 | 334.031 | 302.635 | 290.368 | 317.683 | 292.06 | 411.633 | 388.967 | 402.707 | 474.746 | 492.91 | 489.895 | 567.556 | 621.078 | 649.745 | 507.267 | 570.326 | 534.077 | 616.6 | 471.366 | 509.251 | 489.715 |
| Cost of Revenue
| 66.959 | 88.63 | 80.693 | 83.728 | 70.395 | 68.904 | 83.54 | 84.508 | 63.758 | 63.383 | 51.945 | 62.628 | 50.485 | 90.37 | 229.22 | 203.924 | 220.183 | 225.961 | 202.764 | 277.076 | 301.032 | 282.474 | 345.464 | 322.903 | 362.344 | 405.493 | 457.843 | 453.68 | 356.727 | 407.265 | 376.082 | 439.966 | 327.842 | 287.567 | 434.429 |
| Gross Profit
| 51.202 | 40.936 | 64.687 | 89.213 | 42.672 | 67.015 | 73.867 | 117.732 | 70.646 | 71.612 | 83.408 | 72.221 | 56.35 | 70.601 | 104.811 | 98.711 | 70.185 | 91.721 | 89.296 | 134.556 | 87.935 | 120.232 | 129.282 | 170.007 | 127.551 | 162.063 | 163.235 | 196.065 | 150.54 | 163.061 | 157.995 | 176.634 | 143.524 | 221.684 | 55.286 |
| Gross Profit Ratio
| 0.433 | 0.316 | 0.445 | 0.516 | 0.377 | 0.493 | 0.469 | 0.582 | 0.526 | 0.53 | 0.616 | 0.536 | 0.527 | 0.439 | 0.314 | 0.326 | 0.242 | 0.289 | 0.306 | 0.327 | 0.226 | 0.299 | 0.272 | 0.345 | 0.26 | 0.286 | 0.263 | 0.302 | 0.297 | 0.286 | 0.296 | 0.286 | 0.304 | 0.435 | 0.113 |
| Reseach & Development Expenses
| 5.923 | 7.156 | 5.779 | 8.829 | 6.609 | 7.22 | 8.258 | 13.244 | 6.975 | 6.759 | 7.291 | 7.448 | 8.924 | 6.781 | 6.091 | 5.343 | 7.382 | 5.701 | 4.03 | 15.103 | 6.08 | 9.488 | 5.616 | 6.995 | 10.371 | 17.173 | 7.795 | 3.568 | 7.452 | 24.482 | 0 | 35.118 | 0 | 5.917 | 0 |
| General & Administrative Expenses
| 0 | -17.25 | 33.483 | -67.702 | 83.905 | -15.102 | 31.872 | -71.165 | 83.658 | -12.718 | 36.19 | -54.578 | 70.978 | -14.088 | 30.039 | -56.465 | 34.887 | -8.795 | 32.173 | -57.819 | 32.474 | -10.339 | 32.246 | -54.887 | 23.231 | -22.743 | 38.58 | -81.956 | 38.902 | 35.418 | 34.879 | -70.075 | 41.123 | 46.769 | 0 |
| Selling & Marketing Expenses
| 0 | 33.449 | 49.165 | 40.99 | 28.964 | 52.407 | 57.915 | 99.458 | 57.554 | 52.759 | 57.313 | 24.592 | 47.318 | 66.253 | 90.267 | 98.191 | 54.096 | 81.809 | 66.387 | 155.203 | 129.958 | 62.131 | 62.852 | 204.819 | 68.022 | 54.722 | 42.691 | 45.013 | 48.696 | 57.945 | 37.708 | 51.493 | 31.522 | 95.531 | 0 |
| SG&A
| 56.395 | 54.662 | 83.976 | -26.712 | 112.869 | 37.305 | 89.787 | 28.293 | 141.212 | 40.041 | 93.502 | -29.985 | 118.296 | 52.165 | 120.306 | 41.726 | 88.983 | 73.014 | 98.56 | 97.385 | 162.432 | 51.792 | 95.098 | 149.932 | 91.253 | 31.979 | 81.272 | -36.942 | 87.598 | 109.098 | 72.587 | -18.582 | 72.645 | 149.857 | 0 |
| Other Expenses
| -0.29 | -3.734 | -0.209 | 2.973 | -4.858 | 1.117 | -8.978 | 74.857 | -53.809 | 52.916 | -3.474 | 62.623 | -44.327 | 0.242 | -0.306 | -26.914 | -6.237 | -0.562 | -0.523 | -7.503 | -0.369 | 0.162 | -1.37 | -21.799 | -0.826 | -0.74 | -0.173 | -4.699 | -0.462 | -505.834 | -471.809 | 22.209 | 3.168 | -465.38 | -434.43 |
| Operating Expenses
| 62.608 | 65.552 | 89.965 | 82.198 | 69.24 | 96.834 | 89.067 | 116.394 | 94.378 | 99.716 | 97.319 | 40.085 | 82.893 | 93.3 | 121.092 | 140.994 | 90.998 | 127.747 | 85.912 | 207.854 | 153.086 | 111.624 | 101.272 | 254.543 | 93.623 | 95.525 | 62.029 | 66.208 | 76.56 | -505.834 | -471.809 | 91.422 | 75.854 | -465.38 | -434.43 |
| Operating Income
| -11.406 | -24.616 | -25.278 | -9.393 | -29.028 | -39.382 | -15.77 | -17.759 | -23.732 | -28.104 | -13.912 | 10.649 | -28.126 | -18.741 | -24.774 | -396.294 | -34.628 | -61.129 | -8.291 | -160.822 | -70.751 | -5.458 | 16.509 | -104.38 | 33.665 | 52.968 | 78.33 | 113.884 | 69.004 | 64.492 | 62.268 | 80.996 | 58.509 | 43.871 | 55.285 |
| Operating Income Ratio
| -0.097 | -0.19 | -0.174 | -0.054 | -0.257 | -0.29 | -0.1 | -0.088 | -0.177 | -0.208 | -0.103 | 0.079 | -0.263 | -0.116 | -0.074 | -1.309 | -0.119 | -0.192 | -0.028 | -0.391 | -0.182 | -0.014 | 0.035 | -0.212 | 0.069 | 0.093 | 0.126 | 0.175 | 0.136 | 0.113 | 0.117 | 0.131 | 0.124 | 0.086 | 0.113 |
| Total Other Income Expenses Net
| 21.393 | 2.542 | 2.019 | 2.973 | -4.858 | 1.117 | -0.383 | 1.172 | 7.171 | -5.058 | -3.895 | 6.247 | 0.364 | 4.2 | -8.798 | -380.925 | -20.052 | -25.666 | -12.199 | -95.027 | -5.969 | -13.939 | -12.871 | -35.488 | -1.09 | -14.31 | -23.05 | -19.87 | -5.518 | 424.439 | -463.974 | 17.418 | -5.993 | 405.345 | -430.94 |
| Income Before Tax
| 9.987 | -22.073 | -23.26 | -6.42 | -33.886 | -38.264 | -16.153 | -16.587 | -16.561 | -33.162 | -17.806 | 16.896 | -27.762 | -18.499 | -25.08 | -423.208 | -40.864 | -61.691 | -8.815 | -168.325 | -71.12 | -5.331 | 15.139 | -126.178 | 32.839 | 52.228 | 78.157 | 109.987 | 68.462 | 56.698 | 70.103 | 102.63 | 61.678 | 53.843 | 58.775 |
| Income Before Tax Ratio
| 0.085 | -0.17 | -0.16 | -0.037 | -0.3 | -0.282 | -0.103 | -0.082 | -0.123 | -0.246 | -0.132 | 0.125 | -0.26 | -0.115 | -0.075 | -1.398 | -0.141 | -0.194 | -0.03 | -0.409 | -0.183 | -0.013 | 0.032 | -0.256 | 0.067 | 0.092 | 0.126 | 0.169 | 0.135 | 0.099 | 0.131 | 0.166 | 0.131 | 0.106 | 0.12 |
| Income Tax Expense
| 1.624 | -0.944 | -2.492 | 5.097 | -2.789 | -3.108 | -0.211 | 11.574 | -0.2 | -2.237 | -1.699 | 20.858 | -0.345 | -2.803 | 0.184 | -55.453 | 10.398 | 3.024 | 1.038 | -10.278 | -2.643 | -1.846 | 4.07 | 3.453 | -4.505 | 11.779 | 10.697 | 19.122 | 8.823 | 443.051 | -457.582 | 18.404 | 6.87 | 407.512 | -424.46 |
| Net Income
| 6.756 | -22.646 | -20.462 | -11.249 | -31.042 | -34.891 | -15.941 | -28.161 | -16.361 | -30.925 | -16.107 | -3.962 | -27.417 | -15.184 | -25.296 | -371.43 | -50.811 | -59.904 | -8.587 | -159.018 | -69.519 | -4.746 | 10.536 | -34.203 | 35.431 | 43.297 | 66.222 | 89.122 | 57.583 | 45.879 | 55.804 | 82.233 | 51.755 | 41.704 | 48.805 |
| Net Income Ratio
| 0.057 | -0.175 | -0.141 | -0.065 | -0.275 | -0.257 | -0.101 | -0.139 | -0.122 | -0.229 | -0.119 | -0.029 | -0.257 | -0.094 | -0.076 | -1.227 | -0.175 | -0.189 | -0.029 | -0.386 | -0.179 | -0.012 | 0.022 | -0.069 | 0.072 | 0.076 | 0.107 | 0.137 | 0.114 | 0.08 | 0.104 | 0.133 | 0.11 | 0.082 | 0.1 |
| EPS
| 0.021 | -0.071 | -0.064 | -0.035 | -0.098 | -0.11 | -0.05 | -0.089 | -0.052 | -0.097 | -0.051 | -0.013 | -0.086 | -0.048 | -0.08 | -1.17 | -0.16 | -0.19 | -0.027 | -0.5 | -0.22 | -0.015 | 0.033 | -0.11 | 0.11 | 0.14 | 0.21 | 0.27 | 0.18 | 0.14 | 0.23 | 0.34 | 0.21 | 0.17 | 0.2 |
| EPS Diluted
| 0.021 | -0.071 | -0.064 | -0.035 | -0.098 | -0.11 | -0.05 | -0.089 | -0.051 | -0.097 | -0.051 | -0.013 | -0.086 | -0.048 | -0.08 | -1.17 | -0.16 | -0.19 | -0.027 | -0.5 | -0.22 | -0.015 | 0.033 | -0.11 | 0.11 | 0.14 | 0.21 | 0.27 | 0.18 | 0.14 | 0.23 | 0.34 | 0.21 | 0.17 | 0.2 |
| EBITDA
| 14.237 | 3.287 | -18.695 | 13.745 | -29.568 | -26.107 | -13.803 | 3.117 | -15.119 | -26.116 | -13.081 | 35.084 | -26.489 | 1.474 | -16.586 | -66.182 | -26.055 | -36.431 | 3.338 | -72.588 | -65.011 | 9.433 | 25.543 | -107.038 | 34.21 | 56.792 | 112.944 | 106.161 | 70.918 | -392.693 | 534.077 | 103.357 | 68.203 | -351.502 | 489.715 |
| EBITDA Ratio
| 0.12 | 0.025 | -0.129 | 0.079 | -0.262 | -0.192 | -0.088 | 0.015 | -0.112 | -0.193 | -0.097 | 0.26 | -0.248 | 0.009 | -0.05 | -0.219 | -0.09 | -0.115 | 0.011 | -0.176 | -0.167 | 0.023 | 0.054 | -0.217 | 0.07 | 0.1 | 0.182 | 0.163 | 0.14 | -0.689 | 1 | 0.168 | 0.145 | -0.69 | 1 |